Annual Report 2016
Today, as a research-driven pharmaceutical company we focus more than ever on a variety of partnerships. Read more in our Annual Report 2016.
Get an overview of the major consolidated companies and our main business areas Human Pharmaceuticals and Animal Health
Board of Managing Directors
As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of six members. Read more about their respective responsibilities.
Boehringer Ingelheim is a Top Employer
Boehringer Ingelheim achieves the “Top Employer” award in seven countries.
PRESS RELEASE 05 Apr 2017 at 10:30
Successful financial year 2016 for Boehringer Ingelheim
PRESS RELEASE 05 Apr 2017 at 13:00
Boehringer Ingelheim: A New World Leader in Animal Health
PRESS RELEASE 30 Mar 2017 at 14:00
Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries
PRESS RELEASE 02 Mar 2017 at 14:00
Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
PRESS RELEASE 02 Mar 2017 at 09:00
Boehringer Ingelheim sponsors the new building of the Research Institute of Molecular Pathology in Vienna with EUR 52 million
PRESS RELEASE 28 Feb 2017 at 08:00
PRESS RELEASE 15 Feb 2017 at 14:00
Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments